Pharma R&D Today

Ideas and Insight supporting all stages of Drug Discovery & Development

Select category
Search this blog

Impact of Precision Medicine and Genomics on Patient Treatment

Posted on August 26th, 2016 by in Chemistry

In January of 2015, President Barack Obama launched the Precision Medicine Initiative, which brought to the forefront the growing understanding and need for individually tailored and customized treatments for patients.

Continue reading “Impact of Precision Medicine and Genomics on Patient Treatment” »

Molecular Relatives: Prodrugs

Posted on May 19th, 2016 by in Pharma R&D

I’m an avid sailor, and on our boat we have an amazing device known as a water-maker. It is probably one of the most useful pieces of equipment on board for long cruises, as it takes in sea water, and, through a process of reverse osmosis, provides potable drinking water. Continue reading “Molecular Relatives: Prodrugs” »

Transparency for Better Science

Posted on February 10th, 2016 by in Pharma R&D

I like to think of scientific discovery as not unlike parenthood: scientists create a piece of knowledge (like a child), and then release it to its own life in the world (a grown-up child), and, often, that piece of knowledge informs the Continue reading “Transparency for Better Science” »

Monitoring literature for Benefit-Risk Evaluation: a Life-Time Responsibility

Posted on January 15th, 2016 by in Pharmacovigilance

Monitoring worldwide experience

The purpose of drugs is to cure or alleviate symptoms of disease. However, drugs do not only have therapeutic effects, they may also cause adverse drug reactions (ADRs). Continue reading “Monitoring literature for Benefit-Risk Evaluation: a Life-Time Responsibility” »